Beetlebung Pharma Ltd.

High-Tech Company

Acquired by Open Book Extracts

TECH VERTICALS

Life Sciences, Medical Cannabis, MedTech, Pharmaceuticals, Therapeutics

General Data

Sector	Biomed
Company Stage:	Seed
Established	2018
Number of Employees	5
Reg. Number:	abCDe

DESCRIPTION

Beetlebing focuses on the discovery and development of novel cannabis-related pharmaceutical therapeutics.

TECHNOLOGY

Cannabis-related pharmaceutical therapeutics.

Products and Phases

Product	Phase
N/A
Cannabis-related pharmaceutical drug.

	TARGET MARKETS
	Medical cannabis market.

	BUSINESS MODEL
	B2B

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
98C405FD-46D2-EA11-810A-0050569A1018		Salzman Group (SG) Ltd.
	Group	Radikal Therapeutics Inc. (RTX)	Salzman Group (SG) Ltd.
035BE8ED-C90D-E911-80FA-0050569A1018	Spin-off	Beetlebung Pharma Ltd.	Salzman Group (SG) Ltd.	Acquired/Merged
6CF9BAB4-55D2-EA11-810A-0050569A1018	Spin-off	Quitsa Pharmaceuticals Ltd.	Salzman Group (SG) Ltd.
0A997857-364C-E711-80D7-00155D0B832C	Spin-off	Tisbury Pharmaceuticals Ltd.	Radikal Therapeutics Inc. (RTX)	Ceased

CONTACT INFO

Expand / Collapse All

Main Address: Katzrin, Israel

Address	23 Erez St.
City	Katzrin
Country	Israel
Zip	1290000

Contact Person	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Ms. Nedira Salzman	CEO
Dr. Andrew L. Salzman	Founder

	BOARD

Board

Member	Title	Affiliation
abC Defghij	Chairman	Founder, Beetlebung

Mergers & Acquisitions

Round

Date

Stage

Amount

Valuation

Acquired

Jun. 15, 2020

abCDe

	FINANCIAL ROUNDS

Total Capital Raised
abCDe

Financial Rounds

Numbers of Investors

Expand / Collapse All

Round

Date

Stage

Amount

Valuation

Seed

Feb. 01, 2018

Seed

abCDe

	R&D Grants

Expand / Collapse All

Round

Date

Stage

Amount

Remarks

R&D Grant

Jul. 19, 2018

Seed

abCDe

* New investor

Investor	Type	Amount	Remarks
abC Defghij	High-Tech Company	abCDe

Last Updated:	abCDe
IVC Number:	abCDe